Welcome to neditol.co.uk
Neditol® XL is a prolonged-release capsule of tolterodine tartrate indicated in symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.1
- 4mg prolonged-release capsules
- 2mg prolonged-release capsules (available for the first time in the UK)
Neditol XL is bioequivalent to Detrusitol® XL (Pfizer Limited, Surrey, UK).2
Neditol XL offers significant savings to your practice and clinical commissioning group (CCG).
Typically generic products are listed in category M of the UK Drug Tariff. On patent expiry of the originator product, the market price then declines significantly and savings are eventually passed on to the practice or CCG.
However, category C Drug Tariff products are often more difficult to manufacture and their reimbursed price remains the same whether it be an originator product or generic. Tolterodine 4mg prolonged-release capsules are in category C of the Drug Tariff.3
Neditol XL is different as Aspire Pharma have priced the product with the Department of Health to give your practice or CCG savings of up to 50% on the cost of the Category C Drug Tariff price for tolterodine 4mg prolonged-release capsules when Neditol XL is prescribed by brand.3*
At CCG level, the average cost of tolterodine XL prescribing is >£160,000. A change to Neditol XL would result in prescribing savings >£80,100.4**
In addition to making 50% cost savings,* Neditol XL:
• Available from mainline wholesalers;
• High level of stockholdings;
• Price guaranteed till 2019;***
• Bioequivalent to the originator brand;2
• Additional 2mg strength.